Key questions on ovarian and breast cancer genetics (1.5 CPD hours)
23 May 2014
FULL CPD MODULE
This module will update your knowledge on ovarian and breast cancer genetics, including:
- The reliability of negative genetic testing
- Risk reduction strategies that moderate/high-risk women should consider
- The implications regarding contraception and HRT for women at high or moderate risk
- Who should be considered for chemoprevention or prophylactic mastectomy
- Who would warrant genetic testing for the BRCA1 or BRCA2 gene
Portfolio careers
What is the right portfolio career for you?
Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.
